ferric saccharose
Small moleculeexperimental
Clinical trial activity
4 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2003 (NCT00210002)
Timeline
2000s
- Jan 1, 2003
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- IronSupplementation
Iron supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ferric hydroxide saccharate
- ferric saccharose
- iron hydroxide saccharate
- noripurum
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04310514 | N/A | Mar 9, 2020 | Medical University of Gdansk |
| NCT02335593 | Phase 2 | Dec 1, 2014 | Ain Shams University |
| NCT01168505 | Phase 2 | May 1, 2010 | Instituto do Cancer do Estado de São Paulo |
| NCT00210002 | Phase 2 | Nov 1, 2003 | University of Toulouse |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Ain Shams University | Academic/Hospital | 1 | 1 | 1 | 2014 |
| Instituto do Cancer do Estado de São Paulo | Academic/Hospital | 1 | 1 | 1 | 2010 |
| Medical University of Gdansk | Academic/Hospital | 1 | 1 | 1 | 2020 |
| University of Toulouse | Academic/Hospital | 1 | 1 | 1 | 2003 |
4 organizations
Page 1 / 1